Directa Plus Regulatory News (DCTA)

21 November 2022

Directa Plus plc

("Directa Plus" or the "Company")

Board Changes

Appointment of Non-Executive Director

Directa Plus (AIM: DCTA), a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets, is pleased to announce the appointment of Sarah Cope as a Non-executive director. Sarah has over 20 years' experience as an investment banker in London, advising small and mid-sized companies on corporate governance, strategy, amalgamations and disposals, capital markets and regulatory compliance. She has predominantly advised AIM listed companies in the Oil and Gas sector, assisting publicly traded companies to raise finance for their exploration, development and production projects around the world.

Following this appointment, Neil Warner has stepped down from the Board. As a consequence, Sarah will be nominated to take over from Neil as the Chair of the Audit Committee.

Giulio Cesareo, Founder and Chief Executive of Directa Plus, commented: "We are delighted to welcome Sarah Cope to the Board. She is a capital markets professional whose significant experience and knowledge, particularly in our key oil vertical, will help us with our next phase of development as we address global decontamination markets with Grafysorber®.

"On behalf of the Board and shareholders, I would like to express our deep thanks to Neil for his contribution to Directa Plus since our IPO in 2016 and wish him well for the future."

Sarah Cope, added: "I am excited to join the Directa Plus Board as a Non-executive director. My time in capital markets advising growth companies in oil and gas will be directly relevant as will my experience of strategy, governance and regulatory compliance where I certainly share Directa Plus's views on sustainability and transparency."

For further information please visit http://www.directa-plus.com/ or contact:

Notes to Editors

Directa Plus (www.directa-plus.com) is one of the largest producers and suppliers of graphene-based products for use in consumer and industrial markets. The Company's graphene manufacturing capability uses proprietary patented technology based on a plasma super expansion process. Starting from natural graphite, each step of Directa Plus' production process - expansion, exfoliation and drying - creates graphene-based materials and hybrid graphene materials ready for a variety of uses and available in various forms such as powder, liquid and paste.

This proprietary production process uses a physical process, rather than a chemical process, to process graphite into pristine graphene nanoplatelets, which enables Directa Plus to offer a sustainable, non-toxic product, without unwanted by-products. Directa Plus' products are made of hybrid graphene materials and graphene nano-platelets. The products (marketed as G+®) have multiple applications due to its properties. These G+® products can be categorised into various families, with different products being suitable for specific practical applications.

Directa Plus was established in 2005 and is based in Lomazzo (Como, Italy) and has been listed on the AIM market of the London Stock Exchange since May 2016. Directa Plus holds the Green Economy Mark from London Stock Exchange which recognises companies that contribute to the global green economy.

The following information regarding the appointment of Sarah Cope (aged 50) is required to be disclosed under Schedule 2(g) of the AIM Rules for Companies:

There are no further disclosures to be made under Schedule 2(g) of the AIM Rules for Companies.

-ends-